Tag: hepatic failure
-
Ocaliva FDA Adverse Events Reports for Hepatobiliary System Cases: An Analysis as of October 2020
Lack of Warnings in Current Ocaliva Drug Label for Some Serious Side Effects Involving Liver, Gallbladder, Bile Ducts (Posted by Tom Lamb at DrugInjuryWatch.com) We are still wondering how the current FDA…
-
Ocaliva Black-Box Warning About Liver Failure Due To Incorrect Doses Added In Early 2018
This Ocaliva Label Change Follows September 2017 Dear Doctor Letter Sent By Intercept Pharmaceuticals (Posted by Tom Lamb at DrugInjuryWatch.com) An earlier blog post, "Will Ocaliva Get Black-Box Warning For Liver Injury…
-
2018 Emerging Drug Litigations: Mirena IUD and Ocaliva
Additional information concerning the potentially harmful side effects of the Mirena IUD and Ocaliva was released over the course of 2017, and we will continue to monitor the situation in 2018.
-
Harvoni, Sovaldi, Viekira Pak, And Other Direct-Acting Antivirals Get Black-Box Warning: Risk Of Hepatitis B Virus Reactivation
October 2016 FDA Drug Safety Communication Warns About These Relatively New Drugs Which Are Increasingly Popular For Treating Chronic Hepatitis C (Posted by Tom Lamb at DrugInjuryWatch.com) UPDATE: “New Safety Issue:…
-
Xarelto: Drug-Induced Liver Injury Reports Received By Health Canada And Found In Medical Literature
Should New Liver Side Effects Warning Be Added By Janssen Pharmaceuticals To Prescribing Information For Xarelto? (Posted by Tom Lamb at DrugInjuryWatch.com) In the August 2015 edition of the Health Product InfoWatch…
-
Xarelto: Drug-Induced Liver Injury Warning Should Be Added To Drug Label Prescribing Information For Xarelto Say Medical Researchers
Medical Journal Article Reports On Two Patients Who Experienced Severe Liver Damage Onset During Xarelto Treatment (Posted by Tom Lamb at DrugInjuryWatch.com) Most adverse drug reaction case reports associated with the still relatively new anticoagulant Xarelto (rivaroxaban)…
-
Antibiotics Levaquin And Avelox Linked To Increased Risk Of Liver Injury In Older Patients According To New Canadian Study
August 2012 CMAJ Medical Journal Article Adds To Hepatotoxicity Evidence Against These Two Fluoroquinolone Drugs (Posted by Tom Lamb at DrugInjuryWatch.com) According to a case-control study published by the Canadian Medical Association Journal (CMAJ)…